临床试验

Randomized Double-Blind Trial on Safety and Efficacy of Nanordica Advanced Antibacterial Wound Dressing for Diabetic Foot Ulcer

NCT：NCT06667752 · ACTIVE_NOT_RECRUITING

NCT编号NCT06667752

状态ACTIVE_NOT_RECRUITING

开始日期2024-10-17

完成时间2026-12-31

SponsorNanordica Medical OU (INDUSTRY)

First posted2024-10-31

Last updated2026-09-18

简要摘要

This clinical trial evaluates the safety and efficacy of the Nanordica Advanced Antibacterial Wound Dressing (AAWD) in patients suffering from diabetic foot ulcers. At least 136 participants will be randomly allocated to be treated either with AAWD or Aquacel Ag+ Extra wound dressing for a 4-week active phase (intervention) followed by an 8-week standard of care period.

官方来源

在 ClinicalTrials.gov 上查看 →

数据来自 ClinicalTrials.gov API。有关最新状态，请参阅官方记录。